Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-004796
Filing Date
2025-07-02
Accepted
2025-07-02 16:13:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5292
  Complete submission text file 0001950047-25-004796.txt   6904
Mailing Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183
Business Address PROF. J.H. BAVINCKLAAN 7 AMSTELVEEN Netherlands 1183 49 89 2153 9035
ATAI Life Sciences N.V. (Subject) CIK: 0001840904 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40493 | Film No.: 251101130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ATAI LIFE SCIENCES N.V. WALLSTRASSE 16 BERLIN 2M 10179
Business Address
Kirpekar Sahil (Reporting) CIK: 0001951712 (see all company filings)

Type: 144